by Alex Kadhim
Researchers from Siriraj Hospital, Mahidol University in Thailand demonstrated that haploidentical hematopoietic stem cell transplantation (haplo-HSCT), combined with post-transplant...
by Ami Bhatt, MD, PhD
This spotlight features Ami Bhatt, MD, PhD, the newly appointed Director of Laboratory Science on the ASTCT Board of Directors. A physician-scientist at Stanford University, Dr. Bhatt’s work...
by ASTCT Talks
In this episode of ASTCT Talks, Dr. Shernan Holtan welcomes Andrew Lin, Manager of Clinical Pharmacy Services of Adult BMT and CTS at Memorial Sloan Kettering Cancer Center, to discuss the...
by Alex Kadhim
Researchers from Massachusetts General Hospital and collaborating institutions conducted a prospective, multicenter phase II clinical trial demonstrating that prolonged administration of...
by Alex Kadhim
In a recent study, researchers from the University of California, San Francisco, have demonstrated that high exposure to melphalan significantly increases the risk of graft-versus-host disease...
by Cancer Immunology, Immunotherapy
Scientists believe prostaglandin F2 receptor negative regulator (PTGFRN) is a possible target for chimeric antigen receptor (CAR) T-cell therapy in patients with glioblastoma (GBM).